NCT07112001 A Behavioral mHealth Intervention for People With HIV With Anxiety and Depression
| NCT ID | NCT07112001 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-07-31 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-07-31 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will adapt and assess the preliminary effectiveness of a community health worker-delivered mental health counselling intervention delivered remotely to reduce anxiety and depression among people with HIV in Florida.
Eligibility Criteria
Inclusion Criteria: * HIV diagnosis * GAD-7 score of 5 or greater * PHQ-8 score of 5 or greater Exclusion Criteria: * Active psychosis * Suicidal ideation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07112001 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07112001 currently recruiting?
Yes, NCT07112001 is actively recruiting participants. Contact the research team at preeti.manavalan@medicine.ufl.edu for enrollment information.
Where is the NCT07112001 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT07112001 clinical trial?
NCT07112001 is sponsored by University of Florida. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.